Dss Inc. insider trades
Open-market stock purchases and sales by Dss Inc., 10% Owner at Impact Biomedical Inc, from SEC Form 4 filings since Sep 29, 2021.
Track record: 13% of 30 scored buys are up 5% or more since purchase, averaging -52%.
Open-market stock purchases and sales by Dss Inc., 10% Owner at Impact Biomedical Inc, from SEC Form 4 filings since Sep 29, 2021.
Track record: 13% of 30 scored buys are up 5% or more since purchase, averaging -52%.